http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 07:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html <p align="justify">SASKATOON, Saskatchewan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- <strong>PharmaCorp Rx Inc. (TSXV: PCRX)</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) today announced changes to its Board of Directors, Board committee leadership and Corporate Secretary as the Corporation prepares for its 2026 Annual General and Special Meeting of Security Holders (the “<strong>2026 AGSM</strong>”).</p> <p align="justify">Effective August 31, 2026, Calvin Leroux will step down as a director of PharmaCorp and as Chair of the Corporation’s Corporate Governance and Compensation Committee. Mr. Leroux has advised the Corporation that he will not stand for re-election at the 2026 AGSM, which is being held on October 8, http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Board+and+Committee+Changes/26984736.html Thu, 27 Aug 2026 07:30:00 -0400 A.36078215 A.39239393 A.50114186 O.02555813 O.05079510 O.50605477 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html <ul type="square"><li>Second quarter 2026 revenue up 75.8% compared to the second quarter of 2025</li><li>Second quarter 2026 gross profit increased 78.2% compared to the second quarter of 2025</li><li style="text-align:justify;">Second quarter same-store sales were up 3.8%, and same-store prescription sales were up 5.2%, both compared to the second quarter of 2025 <br/><br/></li></ul> <p align="justify">SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>PHARMACORP RX INC.</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.</p> <p align="justify">“Our second quarter reflected continued organic http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html Thu, 20 Aug 2026 07:30:00 -0400 O.53471682 PCRX http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html <ul type="square"><li>Second quarter 2026 revenue up 75.8% compared to the second quarter of 2025</li><li>Second quarter 2026 gross profit increased 78.2% compared to the second quarter of 2025</li><li style="text-align:justify;">Second quarter same-store sales were up 3.8%, and same-store prescription sales were up 5.2%, both compared to the second quarter of 2025 <br/><br/></li></ul> <p align="justify">SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>PHARMACORP RX INC.</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.</p> <p align="justify">“Our second quarter reflected continued organic http://www.streetinsider.com/Press+Releases/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html Thu, 20 Aug 2026 07:30:00 -0400 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html <ul type="square"><li>Second quarter 2026 revenue up 75.8% compared to the second quarter of 2025</li><li>Second quarter 2026 gross profit increased 78.2% compared to the second quarter of 2025</li><li style="text-align:justify;">Second quarter same-store sales were up 3.8%, and same-store prescription sales were up 5.2%, both compared to the second quarter of 2025 <br/><br/></li></ul> <p align="justify">SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>PHARMACORP RX INC.</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.</p> <p align="justify">“Our second quarter reflected continued organic http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html Thu, 20 Aug 2026 07:30:00 -0400 O.53471682 PCRX http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html <ul type="square"><li>Second quarter 2026 revenue up 75.8% compared to the second quarter of 2025</li><li>Second quarter 2026 gross profit increased 78.2% compared to the second quarter of 2025</li><li style="text-align:justify;">Second quarter same-store sales were up 3.8%, and same-store prescription sales were up 5.2%, both compared to the second quarter of 2025 <br/><br/></li></ul> <p align="justify">SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) -- <strong>PHARMACORP RX INC.</strong> (“<strong>PharmaCorp</strong>” or the “<strong>Corporation</strong>”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.</p> <p align="justify">“Our second quarter reflected continued organic http://www.streetinsider.com/Globe+Newswire/PharmaCorp+Rx+Inc.+Announces+Second+Quarter+2026+Financial+Results/26952868.html Thu, 20 Aug 2026 07:30:00 -0400 O.53471682 PCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Aug+17++Filed+by%3A+SLONIN+JONATHAN/26945496.html si-local-file:///var/storage/secattach/20260818/26945496.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Aug+17++Filed+by%3A+SLONIN+JONATHAN/26945496.html Tue, 18 Aug 2026 17:21:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Aug+17++Filed+by%3A+SLONIN+JONATHAN/26945496.html si-local-file:///var/storage/secattach/20260818/26945496.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Pacira+BioSciences%2C+Inc.++For%3A+Aug+17++Filed+by%3A+SLONIN+JONATHAN/26945496.html Tue, 18 Aug 2026 17:21:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+SLONIN+JONATHAN/26936752.html si-local-file:///var/storage/secattach/20260817/26936752.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+SLONIN+JONATHAN/26936752.html Mon, 17 Aug 2026 11:54:00 -0400 O.00168667 PCRX http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+SLONIN+JONATHAN/26936752.html si-local-file:///var/storage/secattach/20260817/26936752.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Pacira+BioSciences%2C+Inc.+++++++++++++++Filed+by%3A+SLONIN+JONATHAN/26936752.html Mon, 17 Aug 2026 11:54:00 -0400 O.00168667 PCRX http://www.streetinsider.com/New+Coverage/Truist+Securities+Reinstates+Pacira+Pharmaceuticals+%28PCRX%29+at+Buy/26934303.html <p>Truist Securities analyst Anish Nikhanj reinstates coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) with a Buy rating and a price target of $30.00.</p><p>For an analyst ratings summary and ratings history on Pacira Pharmaceuticals <a href="http://www.streetinsider.com/rating_history.php?q=PCRX">click here</a>. For more ratings news on Pacira Pharmaceuticals <a href="http://www.streetinsider.com/stock_lookup_news.php?q=PCRX&amp;type=analyst">click here</a>.</p><p>Shares of Pacira Pharmaceuticals closed at $23.00 yesterday.</p> http://www.streetinsider.com/New+Coverage/Truist+Securities+Reinstates+Pacira+Pharmaceuticals+%28PCRX%29+at+Buy/26934303.html Mon, 17 Aug 2026 06:14:24 -0400 PCRX